NEW YORK, Feb. 12, 2025 /PRNewswire/ -- Report on how AI is driving market transformation - The preclinical software for…
VANCOUVER, BC, Feb. 11, 2025 /PRNewswire/ - Human in Motion Robotics, a leading innovator in robotic mobility and humanoid technology,…
USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, Feb. 11, 2025 /PRNewswire/ -- USA News Group…
MIAMI, Feb. 11, 2025 /PRNewswire/ -- Virtual Vision Health, a leader in Virtual Reality (VR) eye care technology, announced today the…
San Juan, Puerto Rico--(Newsfile Corp. - February 11, 2025) - Hemostemix PR Inc. proudly congratulates Luis Muñoz Marín International Airport…
Minneapolis, MN, Feb. 11, 2025 (GLOBE NEWSWIRE) -- United Theranostics, a leading provider of radiopharmaceutical therapy and supportive molecular imaging…
UK regulatory approval follows FemaSeed, FemVue and FemCerv clearance/ approvals in the U.S., Europe, Canada and IsraelATLANTA, Feb. 11, 2025…
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the…
EMERYVILLE, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing…
Tom Equels, CEO of AIM ImmunoTech and Professor Casper H.J. van Eijck, MD, PhD, Pancreato-biliary Surgeon at Erasmus MC, discuss…